Last reviewed · How we verify
Evidence-based medical care for Acute Coronary Syndrome
Evidence-based medical care for Acute Coronary Syndrome is a Small molecule drug developed by Hoffmann-La Roche. It is currently in Phase 3 development.
At a glance
| Generic name | Evidence-based medical care for Acute Coronary Syndrome |
|---|---|
| Sponsor | Hoffmann-La Roche |
| Modality | Small molecule |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- Effect of Early Educational Intervention on Cardiovascular Risk Factors After Acute Coronary Syndrome (NA)
- Polypill in Acute Coronary Syndrome (PHASE2)
- A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome (PHASE3)
- Knowledge Translation for Patients With Acute Coronary Syndromes (NA)
- Monitoring and Adjustment of Medication Therapy for Patients With Heart Disease (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Evidence-based medical care for Acute Coronary Syndrome CI brief — competitive landscape report
- Evidence-based medical care for Acute Coronary Syndrome updates RSS · CI watch RSS
- Hoffmann-La Roche portfolio CI
Frequently asked questions about Evidence-based medical care for Acute Coronary Syndrome
What is Evidence-based medical care for Acute Coronary Syndrome?
Evidence-based medical care for Acute Coronary Syndrome is a Small molecule drug developed by Hoffmann-La Roche.
Who makes Evidence-based medical care for Acute Coronary Syndrome?
Evidence-based medical care for Acute Coronary Syndrome is developed by Hoffmann-La Roche (see full Hoffmann-La Roche pipeline at /company/roche).
What development phase is Evidence-based medical care for Acute Coronary Syndrome in?
Evidence-based medical care for Acute Coronary Syndrome is in Phase 3.